• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性激素与肝癌

Sex hormones and liver cancer.

作者信息

De Maria Nicola, Manno Mauro, Villa Erica

机构信息

Department of Medicine, Division of Gastroenterology, School of Medicine, University of Modena, Modena, Italy.

出版信息

Mol Cell Endocrinol. 2002 Jul 31;193(1-2):59-63. doi: 10.1016/s0303-7207(02)00096-5.

DOI:10.1016/s0303-7207(02)00096-5
PMID:12161002
Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancy in the world and it usually occurs in individuals with chronic liver disease. The neoplasm is predominant in the male gender, where it is characterized also by a worst prognosis than in females. The pathogenesis of HCC is obscure. Because of its striking male predominance, androgens have been investigated as potential factors able to induce or at least promote hepatic carcinogenesis; this hypothesis has been also supported by the ability of androgens of inducing liver neoplasms in experimental models. On the other hand, due to the fact that HCC occurs predominantly in male cirrhotics who present a characteristic hormone imbalance with a relative hyperestrogenic state, the potential role of estrogen in liver cancer has been studied as well. In this paper, the potential role of sex hormones in liver carcinogenesis has been reviewed.

摘要

肝细胞癌(HCC)是世界上最常见的恶性肿瘤之一,通常发生于患有慢性肝病的个体。该肿瘤在男性中更为常见,其预后也比女性更差。HCC的发病机制尚不清楚。由于其明显的男性优势,雄激素已被研究为可能诱导或至少促进肝癌发生的潜在因素;这一假设也得到了雄激素在实验模型中诱导肝脏肿瘤能力的支持。另一方面,由于HCC主要发生在患有特征性激素失衡且处于相对高雌激素状态的男性肝硬化患者中,雌激素在肝癌中的潜在作用也得到了研究。本文综述了性激素在肝癌发生中的潜在作用。

相似文献

1
Sex hormones and liver cancer.性激素与肝癌
Mol Cell Endocrinol. 2002 Jul 31;193(1-2):59-63. doi: 10.1016/s0303-7207(02)00096-5.
2
Sex-steroids and primary hepatocellular carcinoma.性类固醇与原发性肝细胞癌
Anticancer Res. 1987 Sep-Oct;7(5B):1071-7.
3
Risk factors associated with the use of sex hormones.与使用性激素相关的风险因素。
Anticancer Res. 1987 Sep-Oct;7(5B):943-8.
4
Hepatocellular carcinoma and sex hormones.肝细胞癌与性激素
HPB Surg. 1992;6(1):1-6. doi: 10.1155/1992/72761.
5
[HEPATOCELLULAR CARCINOMA. GENDER ASPECTS OF CARCINOGENESIS].[肝细胞癌。致癌作用的性别方面]
Eksp Klin Gastroenterol. 2016(7):4-12.
6
Endocrine treatment of hepatocellular carcinoma. Any evidence of benefit?肝细胞癌的内分泌治疗。有获益的证据吗?
Eur J Cancer. 1998 Jan;34(1):25-32. doi: 10.1016/s0959-8049(97)00317-1.
7
Male predominance in hepatocellular carcinoma: new insight and a possible therapeutic alternative.肝细胞癌中的男性优势:新见解及一种可能的治疗选择。
Med Hypotheses. 2000 Oct;55(4):348-50. doi: 10.1054/mehy.2000.1066.
8
Sex hormones and risk of liver tumor.性激素与肝肿瘤风险
Ann N Y Acad Sci. 2006 Nov;1089:228-36. doi: 10.1196/annals.1386.044.
9
Altered androgen metabolism eventually leads hepatocellular carcinoma to an impaired hormone responsiveness.雄激素代谢改变最终导致肝细胞癌激素反应受损。
Mol Cell Endocrinol. 2002 Jul 31;193(1-2):51-8. doi: 10.1016/s0303-7207(02)00095-3.
10
Hepatocellular carcinoma in alcoholic cirrhosis: is sex hormone imbalance a pathogenetic factor?酒精性肝硬化中的肝细胞癌:性激素失衡是一个致病因素吗?
Eur J Gastroenterol Hepatol. 1995 Feb;7(2):145-50.

引用本文的文献

1
Sex and gender disparities in hepatocellular carcinoma: insights into risk, diagnosis, and therapeutic outcomes.肝细胞癌中的性别差异:对风险、诊断和治疗结果的见解。
Clin Transl Oncol. 2025 Jun 17. doi: 10.1007/s12094-025-03965-3.
2
Total testosterone, sex hormone-binding globulin, and free testosterone concentrations and risk of primary liver cancer: A prospective analysis of 200,000 men and 180,000 postmenopausal women.总睾酮、性激素结合球蛋白及游离睾酮浓度与原发性肝癌风险:对200,000名男性和180,000名绝经后女性的前瞻性分析。
Int J Cancer. 2025 Apr 15;156(8):1518-1528. doi: 10.1002/ijc.35244. Epub 2024 Nov 5.
3
Tamoxifen for adults with hepatocellular carcinoma.
他莫昔芬治疗肝细胞癌成人患者。
Cochrane Database Syst Rev. 2024 Aug 12;8(8):CD014869. doi: 10.1002/14651858.CD014869.pub2.
4
Assessing Physicians' Recommendations for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Testing Among Minority Populations in Greater Philadelphia and New York City.评估费城及纽约市少数族裔人群中医生对乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)检测的建议。
J Community Health. 2024 Aug;49(4):588-597. doi: 10.1007/s10900-023-01316-3. Epub 2024 Jan 29.
5
Conditional survival probability of distant-metastatic hepatocellular carcinoma: A population-based study.远处转移性肝细胞癌的条件生存概率:一项基于人群的研究。
World J Gastrointest Oncol. 2023 Nov 15;15(11):1874-1890. doi: 10.4251/wjgo.v15.i11.1874.
6
Endogenous sex steroid hormones and risk of liver cancer among US men: Results from the Liver Cancer Pooling Project.美国男性体内内源性性激素与肝癌风险:肝癌合并项目的结果
JHEP Rep. 2023 Mar 22;5(7):100742. doi: 10.1016/j.jhepr.2023.100742. eCollection 2023 Jul.
7
Androgen Receptor Activation Induces Senescence in Thyroid Cancer Cells.雄激素受体激活诱导甲状腺癌细胞衰老。
Cancers (Basel). 2023 Apr 7;15(8):2198. doi: 10.3390/cancers15082198.
8
Urinary Metabolic Profiling of Liver Fluke-Induced Cholangiocarcinoma-A Follow-Up Study.肝吸虫诱发胆管癌的尿液代谢谱分析——一项随访研究
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):203-217. doi: 10.1016/j.jceh.2022.11.012. Epub 2022 Nov 26.
9
Overexpression of CYP11A1 recovers cell cycle distribution in renal cell carcinoma Caki-1.CYP11A1的过表达可恢复肾细胞癌Caki-1中的细胞周期分布。
Cancer Cell Int. 2022 Oct 1;22(1):299. doi: 10.1186/s12935-022-02726-4.
10
Role of estrogen receptors in health and disease.雌激素受体在健康和疾病中的作用。
Front Endocrinol (Lausanne). 2022 Aug 18;13:839005. doi: 10.3389/fendo.2022.839005. eCollection 2022.